Skip to main content
Clinical Trials/NCT06697652
NCT06697652CompletedNot Applicable

Early Readmission After Adrenalectomy for PHEO.

Zagazig University0 sites346 target enrollmentStarted: September 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
346
Primary Endpoint
readmission rate

Study Overview

Brief Summary

to evaluate early hospital enterance after pheo surg.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with pheo

Exclusion Criteria

  • non reactive
  • missed data

Outcomes

Primary Outcomes

readmission rate

Time Frame: 30 days

number of hospital readmission

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Tamer.A.A.M.Habeeb

prof

Zagazig University

Similar Trials

Readmission After Adrenalectomy | Clinical Trial